meta-Hydroxynorephedrine
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
3-(2-amino-1-hydroxypropyl)phenol | |
| Clinical data | |
| Legal status |
|
| Identifiers | |
| CAS Number | 7619-17-2 |
| ATC code | None |
| PubChem | CID 4087 |
| ChemSpider | 3945 |
| Synonyms |
m-hydroxypropadrine m-hydroxyphenylpropanolamine α-methyl-m-octopamine 3,β-dihydroxyamphetamine 3,β-dihydroxy-α-methylphenethylamine |
| Chemical data | |
| Formula | C9H13NO2 |
| Molar mass | 167.205 g/mol |
| |
| |
meta-Hydroxynorephedrine or 3-hydroxynorephedrine, also known as 3,β-dihydroxyamphetamine, is an adrenergic drug of the amphetamine class which was patented as a vasopressor and nasal decongestant but was never marketed.[1][2] It is the racemic form of the sympathomimetic drug metaraminol.
See also
References
- ↑ F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 106. ISBN 978-0-412-46630-4. Retrieved 24 April 2012.
- ↑ Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. p. 2110. ISBN 978-0-8155-1526-5. Retrieved 24 April 2012.
| ||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
